Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets
- Recalling company
- Ajanta Pharma USA Inc
- Product
- Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
- Reason
- Failed Dissolution Specifications: below specification
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Sep 17, 2026
- Reported
- Oct 7, 2026
- Distribution
- Nationwide in the US.
- Status
- Ongoing
- Lot / codes
- Lot: DJ25134, Exp 11/30/2028
- Company location
- Bridgewater, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0010-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0010-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.